前收市價 | 55.68 |
開市 | 55.72 |
買盤 | 55.72 x 1800 |
賣出價 | 55.73 x 800 |
今日波幅 | 55.58 - 55.94 |
52 週波幅 | 53.70 - 83.25 |
成交量 | |
平均成交量 | 10,912,356 |
市值 | 70.133B |
Beta 值 (5 年,每月) | 0.55 |
市盈率 (最近 12 個月) | 9.80 |
每股盈利 (最近 12 個月) | 5.70 |
業績公佈日 | 2024年7月31日 - 2024年8月05日 |
遠期股息及收益率 | 2.66 (4.78%) |
除息日 | 2024年4月19日 |
1 年預測目標價 | 68.76 |
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
FEATURE Shares of CVS Health just went on sale. But like Valentine’s candy in March, just because something is cheap, that doesn’t make it a good buy. Shares of the convenience-store-turned-health-insurance giant plunged 17% Wednesday after it posted earnings that disappointed investors’ already tempered expectations.
Based on the average brokerage recommendation (ABR), CVS Health (CVS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?